References: Community-acquired pneumonia in residents of an aged-care facility

  • Ayaz SI, Haque N, Pearson C, Medado P, Robinson D, Wahl R, et al. Nursing home-acquired pneumonia: course and management in the emergency department. Int J Emerg Med 2014;7:19. https://pubmed.ncbi.nlm.nih.gov/24899929/
  • Dhawan N, Pandya N, Khalili M, Bautista M, Duggal A, Bahl J, et al. Predictors of mortality for nursing home-acquired pneumonia: a systematic review. Biomed Res Int 2015;2015:285983. https://pubmed.ncbi.nlm.nih.gov/25821793/
  • Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, et al. Discontinuing beta-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397(10280):1195-203. https://www.ncbi.nlm.nih.gov/pubmed/33773631
  • Faverio P, Aliberti S, Bellelli G, Suigo G, Lonni S, Pesci A, et al. The management of community-acquired pneumonia in the elderly. Eur J Intern Med 2014;25(4):312-9. https://pubmed.ncbi.nlm.nih.gov/24360244/
  • Fukuyama H, Yamashiro S, Tamaki H, Kishaba T. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother 2013. https://pubmed.ncbi.nlm.nih.gov/23354936/
  • Gallardo R, Gamboa F. Feasibility of subcutaneous antibiotics for palliative care patients. Glob Drugs Therap; 2017. 2 (3):1-5.
  • Garin N, Marti C, Skali Lami A, Prendki V. Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review. Microorganisms 2022;10(12). https://www.ncbi.nlm.nih.gov/pubmed/36557579
  • Jump RLP, Crnich CJ, Mody L, Bradley SF, Nicolle LE, Yoshikawa TT. Infectious Diseases in Older Adults of Long-Term Care Facilities: Update on Approach to Diagnosis and Management. J Am Geriatr Soc 2018;66(4):789-803. https://www.ncbi.nlm.nih.gov/pubmed/29667186
  • Kang YS, Ryoo SR, Byun SJ, Jeong YJ, Oh JY, Yoon YS. Antimicrobial resistance and clinical outcomes in nursing home-acquired pneumonia, compared to community-acquired pneumonia. Yonsei Med J 2017;58(1):180-6. https://pubmed.ncbi.nlm.nih.gov/27873512/
  • Liapikou A, Polverino E, Cilloniz C, Peyrani P, Ramirez J, Menendez R, et al. A worldwide perspective of nursing home-acquired pneumonia compared with community-acquired pneumonia. Respir Care 2014;59(7):1078-85. https://pubmed.ncbi.nlm.nih.gov/24194575/
  • Loeb M, Carusone SC, Goeree R, Walter SD, Brazil K, Krueger P, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006;295(21):2503-10. https://pubmed.ncbi.nlm.nih.gov/16757722/
  • Ma HM, Ip M, Hui E, Chan PK, Hui DS, Woo J. Role of atypical pathogens in nursing home-acquired pneumonia. J Am Med Dir Assoc 2013;14(2):109-13. https://pubmed.ncbi.nlm.nih.gov/23206723/
  • Marrie TJ, File TM, Jr. Bacterial pneumonia in older adults. Clin Geriatr Med 2016;32(3):459-77. https://pubmed.ncbi.nlm.nih.gov/27394017/
  • Muntendam PM, Rene; Shearer, Todd. Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone. Open Forum Infectious Diseases 2016. https://www.researchgate.net/publication/313292580_Pharmacokinetic_Response_after_Subcutaneous_Administration_of_Ceftriaxone
  • Mylotte JM. Nursing Home-Associated Pneumonia, Part II: Etiology and Treatment. J Am Med Dir Assoc 2020;21(3):315-21. https://www.ncbi.nlm.nih.gov/pubmed/32061505
  • Renoncourt T, Dossoubadjiokila J, Mondet L, Pecquet PE, Bennouna N, Gras-Champel V, et al. Evaluation of the tolerance of ceftriaxone by subcutaneous route in patients >/=75 years old in geriatric departments: a prospective observational study. J Antimicrob Chemother 2023;78(6):1495-8. https://www.ncbi.nlm.nih.gov/pubmed/37051882
  • Royer S, DeMerle KM, Dickson RP, Prescott HC. Shorter Versus Longer Courses of Antibiotics for Infection in Hospitalized Patients: A Systematic Review and Meta-Analysis. J Hosp Med 2018;13(5):336-42. https://www.ncbi.nlm.nih.gov/pubmed/29370318
  • Tan SJ, Cockcroft M, Page-Sharp M, Arendts G, Davis TME, Moore BR, et al. Population Pharmacokinetic Study of Ceftriaxone in Elderly Patients, Using Cystatin C-Based Estimates of Renal Function To Account for Frailty. Antimicrob Agents Chemother 2020;64(10). https://www.ncbi.nlm.nih.gov/pubmed/32778543
  • Tansarli GS, Mylonakis E. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother 2018;62(9). https://pubmed.ncbi.nlm.nih.gov/29987137/
  • Teramoto S, Yoshida K, Hizawa N. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir Investig 2015;53(5):178-84. https://pubmed.ncbi.nlm.nih.gov/26344607/
  • Ugajin M, Yamaki K, Hirasawa N, Kobayashi T, Yagi T. Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients. Clin Interv Aging 2014;9:267-74. https://pubmed.ncbi.nlm.nih.gov/24611004/
  • Vaughn VM, Flanders SA, Snyder A, Conlon A, Rogers MAM, Malani AN, et al. Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia: A Multihospital Cohort Study. Ann Intern Med 2019;171(3):153-63. https://www.ncbi.nlm.nih.gov/pubmed/31284301